References
- Zhu N, Zhang D, Wang W, et al. Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
- Guan WJ, Ni JY, Hu Y, et al. clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
- Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382(22):2081–2090.
- Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793.
- Mackey K, Ayers CK, Kondo KK, et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review. Ann Intern Med. 2021;174(3):362–373.
- Raifman MA, Raifman JR. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income. Am J Prev Med. 2020;59(1):137–139.
- [cited 2021 Aug 27]. Available from: https://coronavirus.jhu.edu
- Benatia D, Godefroy R, and Lewis J. Estimating COVID-19 prevalence in the United States: a sample selection model approach (4/15/2020). [cited 2021 Aug 27]. Available at SSRN: https://ssrn.com/abstract=3578760
- Drain PK, Hyle EP, Noubary F, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014;14(3):239–249.
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-molecular.
- Ramanan P, Bryson AL, Binnicker MJ, et al. Syndromic panel-based testing in clinical microbiology. Clin Microbiol Rev. 2017 Nov 15;31(1):e00024–17.
- Brendish NJ, Poole S, Naidu VV, et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 2020Dec8;8(12):1192–1200.
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/media/142193/download
- [cited 2021 Aug 27]. Available from: https://diagnostics.roche.com/us/en/products/params/cobas-sars-cov-2-influenza-a-b-nucleic-acid-test.html
- Hansen G, Marino J, Wang ZX, et al. Clinical performance of the point-of-care cobas liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study. J Clin Microbiol. 2021 Jan 21;59(2):e02811–20.
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/media/142437/download
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/media/142438/download
- Loeffelholz MJ, Alland D, Butler-Wu SM, et al., Multicenter evaluation of the cepheid xpert xpress SARS-CoV-2 Test. J Clin Microbiol. 58(8): e00926–20. 2020.
- Mostafa HH, Carroll KC, Hicken R, et al. Multi-center evaluation of the cepheid xpert® Xpress SARS-CoV-2/Flu/RSV test. J Clin Microbiol. 2020. JCM.02955-20.
- Wolters F, van de Bovenkamp J, van den Bosch B, et al. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic. J Clin Virol. 2020;128:104426.
- Mostafa HH, Hardick J, Morehead E, et al. Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. J Clin Virol. 2020;130:104578.
- Zhen W, Smith E, Manji R, et al. Clinical evaluation of three sample-to-answer platforms for detection of SARS-CoV-2. J Clin Microbiol. 2020;58(8):e00783–20.
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidinvitrodev
- Hogan CA, Garamani N, Lee AS, et al., Comparison of the accula SARS-CoV-2 test with a laboratory-developed assay for detection of SARS-CoV-2 RNA in clinical nasopharyngeal specimens. J Clin Microbiol. 58(8): e01072–20. 2020.
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/media/136525/download
- Rhoads DD, Cherian SS, Roman K, et al. Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA emergency use authorization methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J Clin Microbiol. 2020;58(8):e00760–20.
- Thwe PM, Ren P. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory. Diagn Microbiol Infect Dis. 2020;98(2):115123.
- Dinnes J, Deeks JJ, Adriano A, et al. Cochrane COVID-19 diagnostic test accuracy group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705.
- Mitchell SL, George KS. Evaluation of the COVID19 ID NOW EUA assay. J Clin Virol. 2020;128:104429.
- Smithgall MC, Scherberkova I, Whittier S, et al. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2. J Clin Virol. 2020;128:104428.
- Harrington A, Cox B, Snowdon J, et al. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients. J Clin Microbiol. 2020 Jul 23;58(8):e00798–20.
- Basu A, Zinger T, Inglima K, et al. Performance of Abbott ID Now COVID-19 rapid nucleic acid amplification test using nasopharyngeal swabs transported in viral transport media and dry nasal swabs in a New York City Academic Institution. J Clin Microbiol. 2020;58(8):e01136–20.
- [cited 2021 Aug 27]. Available from: https://www.fda.gov/media/144665/download.
- Pray IW, Ford L, Cole D, et al. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses – Wisconsin, September-October 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1641–1647.
- Dinnes J, Deeks JJ, and Berhane, S, et al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev. 2021; 3. Art. No.: CD013705.
- Pilarowski G, Lebel P, Sunshine S, et al. Performance characteristics of a rapid severe acute respiratory syndrome coronavirus 2 antigen detection assay at a public plaza testing site in San Francisco. J Infect Dis. 2021;223(7):1139–1144. [in press].
- Prince-Guerra J, Almendares O, Nolen LD, et al. Evaluation of Abbott BinaxNow rapid antigen test for SARS-CoV-2 infection at two community-based testing sites – Pima County, Arizona, November 3- 17,2020. MMWR Morb Mortal Wkly Rep. 2021;70:100–105.
- [cited 2021 Aug 27]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guideline
- [cited 2021 Aug 27]. Available from: https://www.idsociety.org/covid-19-real-time-learning-network/diagnostics/rapid-testing/
- [cited 2021 Aug 27]. Available from: https://www.cdc.gov/clia/test-complexities.html
- Lauring AS, Hodcroft EB. Genetic variants of SARS-CoV-2—What do they mean? JAMA. 2021;325(6):529–531.
- Shin DH, Kang M, Song KH, et al. A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea. Clin Microbiol Infect. 2020 Oct 31;27(4):653–655. S1198-743X(20)30655.
- Gonzalez-Zorn B. Antibiotic use in the COVID-19 crisis in Spain. Clin Microbiol Infect. 2020 Nov 25;27(4):646–647. S1198-743X(20)30609-1.
- Spellberg , B , Blaser, M , and Guidos, RJ et al. Infectious Diseases Society of America (IDSA), combating antimicrobial resistance: policy recommendations to save lives. Clinl Infect Dis. 2011 May;52(5):S397–S428.
- The infectious diseases society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing, 12/23/20 [cited 2021 Aug 27]. Available from: , https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/.
- Langford SM, Raybardhan S, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629.
- [cited 2021 Aug 27]. Available from: https://www.cdc.gov/hai/data/portal/progress-report.html
- May L, Gudger G, Armstrong P, et al. Multisite exploration of clinical decision making for antibiotic use by emergency medicine providers using quantitative and qualitative methods. Infect Control Hosp Epidemiol. 2014;35(9):1114–1125.
- Dimopoulou D, Vourli S, Douros K, et al. Use of point-of-care molecular tests reduces hospitalization and oseltamivir administration in children presenting with influenza-like illness. J Med Virol. 2020 Sep 23;93(6):3944–3948. Epub ahead of print.
- Goldstein LN, Wells M, Vincent-Lambert C. Doctors’ perceptions of the impact of upfront point-of-care testing in the emergency department. PLoS One. 2018 Dec 13;13(12):e0208655. e0208655.Erratum in: PLoS One. 2019 Jan 29;14(1):e0211672.
- Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4(6):337–348.
- Sokolowska M, Eiwegger T, Ollert M, et al. Immunology of COVID-19: mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 Oct;75(10):2445–2476.
- Barra GB, Santa Rita TH, Mesquita PG, et al. Overcoming supply shortage for SARS-CoV-2 detection by RT-qPCR. Genes (Basel). 2021;12(1):90.
- Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020 Mar 19;382(12):1177–1179.
- Ozkaynak, Ozkaynak M, Metcalf N, Cohen DM, et al. Considerations for designing EHR-embedded clinical decision support systems for antimicrobial stewardship in pediatric emergency departments. Appl Clin Inform. 2020;11(4):589–597.
- Kuper KM, Nagel JL, Kile JW, et al. The role of electronic health record and “add-on” clinical decision support systems to enhance antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2019;40(5):501–511.
- May, et al. Rapid multiplex testing for upper respiratory pathogens in the emergency department: a randomized controlled trial.Open Forum Infect Dis. 2019 Nov 5;6(12):ofz481.
- Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018 Jul 19;379(3):236–249.
- Yadav K, Meeker D, Mistry RD, et al. A multifaceted intervention improves prescribing for acute respiratory infection for adults and children in emergency department and urgent care settings. Acad Emerg Med. 2019;26(7):719–731.